D. A. Thompson

Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants

Pascal Poignard, Donald E. Mosier, Jill Wilken, 1999, Journal of Virology.

Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5

J. Schlessinger, D. Littman, I. Dikic, 1997, The Journal of experimental medicine.

Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells.

J. Westwick, G. Kolios, K. Petraki, 1999, The Journal of clinical investigation.

In Vivo Inhibition of CC and CX3C Chemokine–induced Leukocyte Infiltration and Attenuation of Glomerulonephritis in Wistar-Kyoto (WKY) Rats by vMIP-II

D. Lo, J. Harrison, Tadashi Yamamoto, 1998, The Journal of experimental medicine.

Genetic Subtype-Independent Inhibition of Human Immunodeficiency Virus Type 1 Replication by CC and CXC Chemokines

A. Trkola, C. Mackay, J. Hoxie, 1998, Journal of Virology.

Presentation of chemokine SDF-1α by fibronectin mediates directed migration of T cells

Philip E. Dawson, Daniel R. Salomon, Bruce E. Torbett, 2000 .

Accessibility of selenomethionine proteins by total chemical synthesis: structural studies of human herpesvirus‐8 MIP‐II

B. Schweitzer, E. Fernandez, M. Siani, 1998, FEBS letters.

Chemically Synthesized SDF-1α Analogue, N33A, Is a Potent Chemotactic Agent for CXCR4/Fusin/LESTR-expressing Human Leukocytes*

W. Gong, Ji Ming Wang, D. Thompson, 1997, The Journal of Biological Chemistry.

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia.

W. Streit, D. Thompson, Y. Xia, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Chemokines and the arrest of lymphocytes rolling under flow conditions.

E. Butcher, D. Thompson, A. Zlotnik, 1998, Science.